Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
Clinical trial NCT02114658 · COMPLETED
Trial details
- NCT number
- NCT02114658
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-15
- Primary completion
- 2015-02-23
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.